Assyro AI

FDA Orange Book · active-ingredient family

Desflurane

Desflurane is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:SUPRANE · NDA 020118

1

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · liquid

ProductApplicantApplicationTEApproved
SUPRANERLDBAXTER HLTHCARENDA 020118ANSep 18, 1992

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
DESFLURANESHANGHAI HENGRUIANDA 208234ANFeb 26, 2018

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Desflurane — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.